Search all trials

Find therapies in clinical trials near you – page 47

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Study on the Safety and Tolerability of Imdusiran and Durvalumab for Patients with Chronic Hepatitis B

Not recruiting

Registered drugNo placebo

Study on the Safety and Tolerability of Imdusiran and Durvalumab for Patients with Chronic Hepatitis B

Registered drugNo placebo

France

Participants:18–64 years
Substances:Ab-729

Contact Research Centre

Colitis ulcerative

Not recruiting

InvestigationalNo placebo

Long-Term Safety Study of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Obefazimod

Contact Research Centre

Non-small cell lung cancer stage IV+1

Not recruiting

Registered drugNo placebo

Study on Lorlatinib for Patients with Advanced ROS1-positive Non-Small Cell Lung Cancer After First-line Treatment Failure

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Lorlatinib

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drug

Study of Amivantamab and Lazertinib Combination vs. Osimertinib vs. Lazertinib for First-Line Treatment in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Amivantamab

Contact Research Centre

Pancreatic carcinoma metastatic

Not recruiting

Registered drugNo placebo

Study of Zolbetuximab with Nab-Paclitaxel and Gemcitabine for Adults with Metastatic Pancreatic Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Gemcitabine

Contact Research Centre

Non-small cell lung cancer

Not recruiting

InvestigationalNo placebo

Study of Davutamig (REGN5093) for Patients with Advanced Non-Small Cell Lung Cancer with MET Alterations

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Davutamig

Contact Research Centre

Pulmonary embolism

Not recruiting

Registered drug

Study on Reduced Dose of Alteplase for Patients with Intermediate-High-Risk Acute Pulmonary Embolism

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Alteplase

Contact Research Centre

Systemic lupus erythematosus

Not recruiting

Registered drug

Study on Ianalumab for Patients with Systemic Lupus Erythematosus

Registered drug

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Emtricitabine

Contact Research Centre

Asthma

Not recruiting

Registered drug

Study Comparing Depemokimab, Mepolizumab, and Benralizumab for Adults and Adolescents with Severe Eosinophilic Asthma

Registered drug

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Benralizumab

Contact Research Centre

Crohn's disease

Not recruiting

Investigational

Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Crohn's Disease

Investigational

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Risankizumab

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study on Livmoniplimab and Budigalimab with Chemotherapy for Adults with Untreated Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Budigalimab

Contact Research Centre

Study on Melanoma Treatment: Comparing Encorafenib and Binimetinib with Ipilimumab and Nivolumab for Patients with BRAF V600 Mutation

Not recruiting

Registered drugNo placebo

Study on Melanoma Treatment: Comparing Encorafenib and Binimetinib with Ipilimumab and Nivolumab for Patients with BRAF V600 Mutation

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Binimetinib

Contact Research Centre

Find therapies in clinical trials near you – page 47

656 trials match your criteria

Study on the Safety and Tolerability of Imdusiran and Durvalumab for Patients with Chronic Hepatitis B

Study on the Safety and Tolerability of Imdusiran and Durvalumab for Patients with Chronic Hepatitis B

Colitis ulcerative

Long-Term Safety Study of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

Non-small cell lung cancer stage IV+1

Study on Lorlatinib for Patients with Advanced ROS1-positive Non-Small Cell Lung Cancer After First-line Treatment Failure

Non-small cell lung cancer

Study of Amivantamab and Lazertinib Combination vs. Osimertinib vs. Lazertinib for First-Line Treatment in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer

Pancreatic carcinoma metastatic

Study of Zolbetuximab with Nab-Paclitaxel and Gemcitabine for Adults with Metastatic Pancreatic Cancer

Non-small cell lung cancer

Study of Davutamig (REGN5093) for Patients with Advanced Non-Small Cell Lung Cancer with MET Alterations

Pulmonary embolism

Study on Reduced Dose of Alteplase for Patients with Intermediate-High-Risk Acute Pulmonary Embolism

Systemic lupus erythematosus

Study on Ianalumab for Patients with Systemic Lupus Erythematosus

Asthma

Study Comparing Depemokimab, Mepolizumab, and Benralizumab for Adults and Adolescents with Severe Eosinophilic Asthma

Crohn's disease

Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Crohn's Disease

Non-small cell lung cancer

Study on Livmoniplimab and Budigalimab with Chemotherapy for Adults with Untreated Metastatic Non-Small Cell Lung Cancer

Study on Melanoma Treatment: Comparing Encorafenib and Binimetinib with Ipilimumab and Nivolumab for Patients with BRAF V600 Mutation

Study on Melanoma Treatment: Comparing Encorafenib and Binimetinib with Ipilimumab and Nivolumab for Patients with BRAF V600 Mutation

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.